<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Although postchallenge <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> is a well-established feature of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, its association with risk of mortality is uncertain </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, the aim of this study was to assess the independent association of fasting and 2-h <z:chebi fb="105" ids="17234">glucose</z:chebi> levels with <z:hpo ids='HP_0000001'>all</z:hpo>-cause and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) mortality </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We analyzed data from the Second National Health and Nutrition Examination Survey (NHANES II) Mortality Study, a prospective cohort study of U.S. adults examined in the NHANES II, and focused on the 3,092 adults aged 30-74 years who underwent an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test at baseline (1976-1980) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0011420'>Deaths</z:hpo> were identified from U.S. national mortality files from 1976 to 1992 </plain></SENT>
<SENT sid="4" pm="."><plain>To account for the complex survey design, we used SUDAAN statistical software for weighted analysis </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Compared with their normoglycemic counterparts (fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> [FG] &lt; 7.0 and 2-h <z:chebi fb="105" ids="17234">glucose</z:chebi> &lt; 7.8 mmol/l), adults with fasting and postchallenge <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (FG &gt; or =7.0 and 2-h <z:chebi fb="105" ids="17234">glucose</z:chebi> &gt; or =11.1 mmol/l) had a twofold higher risk of <z:hpo ids='HP_0011420'>death</z:hpo> after 16 years of follow-up (age- and sex-adjusted relative hazard [RH] 2.1, 95% CI 1.4-3.2) </plain></SENT>
<SENT sid="6" pm="."><plain>However, adults with isolated postchallenge <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (FG &lt; 7.0 and 2-h <z:chebi fb="105" ids="17234">glucose</z:chebi> &gt; or =11.1 mmol/l) were also at higher risk of <z:hpo ids='HP_0011420'>death</z:hpo> (1.6, 1.0-2.6) </plain></SENT>
<SENT sid="7" pm="."><plain>In proportional hazards analysis, FG (fully adjusted RH 1.10 per 1 SD; 95% CI 1.01, 1.22) and 2-h <z:chebi fb="105" ids="17234">glucose</z:chebi> (1.14, 1.00-1.29) showed nearly identical predictive value for mortality </plain></SENT>
<SENT sid="8" pm="."><plain>Similar trends were observed for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> mortality </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These results suggest that postchallenge <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> is associated with increased risk of <z:hpo ids='HP_0000001'>all</z:hpo>-cause and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> mortality independently of other <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk factors </plain></SENT>
</text></document>